CD80 and neoplasm: Further investigations are needed to delineate the role of (a) cellular components (regulatory cells, natural killer cells, etc.)that include costimulatory versus coinhibitory molecules, (b) molecular components (CD28, CD86, CD80, etc.), and (c) cellular mechanisms involved in anti-tumor response.